SKELMET - a German national consortium aimed at unravelling the biology of bone metastases

Skeletal metastases develop in up to 90% of malignancies and frequently cause pathological fractures and severe pain. Multimodal treatment of skeletal metastases is difficult and not causal, in part, because the underlying molecular pathogenesis is poorly understood.    learn more...

 

 

Dresden:	/project 3	/project 8			/Z project
Kiel:	/project 7
Würzburg:	/project 5	/project 9
associated projects:	/project 1	/project 4	/project 6